Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas

Congxiao Wang,Shifeng Liu,Lijing Peng,Kaixian Zhang,Wei Li,Hao Zhang,Ying Luan,Peishun Li,Xiaokun Hu

DOI: https://doi.org/10.1186/s12885-020-07246-w

IF: 4.638

2020-08-07

BMC Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology

What problem does this paper attempt to address?

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Xia Li,Xiufeng Yin,Huafeng Wang,Jiansong Huang,Mengxia Yu,Zhixin Ma,Chenying Li,Yile Zhou,Xiao Yan,ShuJuan Huang,Jie Jin

DOI: https://doi.org/10.18632/oncotarget.27310

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14463.].
Correction to: Molecular landscape of IDH-mutant primary astrocytoma Grade IV/Glioblastomas

Queenie Hoi-Wing Wong,Kay Ka-Wai Li,Wei-Wei Wang,Tathiane M. Malta,Houtan Noushmehr,Yura Grabovska,Chris Jones,Aden Ka-Yin Chan,Johnny Sheung-Him Kwan,Queenie Jun-Qi Huang,Gabriel Chun-Hei Wong,Wen-Cai Li,Xian-Zhi Liu,Hong Chen,Danny Tat-Ming Chan,Ying Mao,Zhen-Yu Zhang,Zhi-Feng Shi,Ho-Keung Ng

DOI: https://doi.org/10.1038/s41379-021-00802-0

IF: 8.209

2021-04-15

Modern Pathology

Abstract:A Correction to this paper has been published: https://doi.org/10.1038/s41379-021-00802-0

pathology
Correction to: GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma

Jing Ning,Shenyi Jiang,Xiaoxi Li,Yang Wang,Xuhong Deng,Zhiqiang Zhang,Lijie He,Daqing Wang,Youhong Jiang

DOI: https://doi.org/10.1186/s12890-021-01715-z

IF: 3.1

2021-11-22

BMC Pulmonary Medicine

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

respiratory system
Author Correction: Suppression of Glioblastoma by a Drug Cocktail Reprogramming Tumor Cells into Neuronal Like Cells

Lei Gao,Shichao Huang,Hong Zhang,Wei Hua,Shunmei Xin,Lin Cheng,Wuqiang Guan,Yongchun Yu,Ying Mao,Gang Pei

DOI: https://doi.org/10.1038/s41598-020-59777-8

IF: 4.6

2020-01-01

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Correction to: LTBP1 plays a potential bridge between depressive disorder and glioblastoma

Xiaojun Fu,Pei Zhang,Hongwang Song,Chenxing Wu,Shengzhen Li,Shouwei Li,Changxiang Yan

DOI: https://doi.org/10.1186/s12967-020-02619-y

IF: 8.44

2020-11-27

Journal of Translational Medicine

Abstract:An amendment to this paper has been published and can be accessed via the original article.

medicine, research & experimental
Correction: A highly X-ray sensitive iridium prodrug for visualized tumor radiochemotherapy

Zhennan Zhao,Pan Gao,Li Ma,Tianfeng Chen

DOI: https://doi.org/10.1039/d1sc90029c

IF: 8.4

2021-01-01

Chemical Science

Abstract:Correction for ’A highly X-ray sensitive iridium prodrug for visualized tumor radiochemotherapy’ by Zhennan Zhao et al. , Chem. Sci. , 2020, 11 , 3780–3789, DOI: 10.1039/D0SC00862A

chemistry, multidisciplinary
Corrigendum: Combined Scutellarin and C18H17NO6 Imperils the Survival of Glioma: Partly Associated With the Repression of PSEN1/PI3K-AKT Signaling Axis

Xiu-Ying He,Yang Xu,Qing-Jie Xia,Xiao-Ming Zhao,Shan Li,Xiao-Qiong He,Ru-Rong Wang,Ting-Hua Wang

DOI: https://doi.org/10.3389/fonc.2022.872110

IF: 4.7

2022-03-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.663262.].

oncology
Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M + diffuse midline gliomas

Michelle Monje,Jasia Mahdi,Robbie Majzner,Kristen W. Yeom,Liora M. Schultz,Rebecca M. Richards,Valentin Barsan,Kun-Wei Song,Jen Kamens,Christina Baggott,Michael Kunicki,Skyler P. Rietberg,Alexandria Sung Lim,Agnes Reschke,Sharon Mavroukakis,Emily Egeler,Jennifer Moon,Shabnum Patel,Harshini Chinnasamy,Courtney Erickson,Ashley Jacobs,Allison K. Duh,Ramya Tunuguntla,Dorota Danuta Klysz,Carley Fowler,Sean Green,Barbara Beebe,Casey Carr,Michelle Fujimoto,Annie Kathleen Brown,Ann-Louise G. Petersen,Catherine McIntyre,Aman Siddiqui,Nadia Lepori-Bui,Katlin Villar,Kymhuynh Pham,Rachel Bove,Eric Musa,Warren D. Reynolds,Adam Kuo,Snehit Prabhu,Lindsey Rasmussen,Timothy T. Cornell,Sonia Partap,Paul G. Fisher,Cynthia J. Campen,Gerald Grant,Laura Prolo,Xiaobu Ye,Bita Sahaf,Kara L. Davis,Steven A. Feldman,Sneha Ramakrishna,Crystal Mackall

DOI: https://doi.org/10.1038/s41586-024-08452-3

IF: 64.8

2024-11-30

Nature

Abstract:Nature - Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas

multidisciplinary sciences
Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Fangling Cheng,Po Zhang,Qungen Xiao,Youwei Li,Minhai Dong,Heping Wang,Dong Kuang,Yue He,Qiuhong Duan,Feng Mao,Baofeng Wang,Dongsheng Guo

DOI: https://doi.org/10.3389/fonc.2020.591112

2020-09-25

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00447.].
Author Correction: Selective, high-contrast detection of syngeneic glioblastoma in vivo

Richard B. Banati,Paul Wilcox,Ran Xu,Grace Yin,Emily Si,Eric Taeyoung Son,Mauricio Shimizu,R. M. Damian Holsinger,Arvind Parmar,David Zahra,Andrew Arthur,Ryan J. Middleton,Guo-Jun Liu,Arnaud Charil,Manuel B. Graeber

DOI: https://doi.org/10.1038/s41598-020-72364-1

IF: 4.6

2020-09-24

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

multidisciplinary sciences
Corrigendum: Neoadjuvant Tislelizumab Combined with Chemotherapy in Locally Advanced Oral or Oropharyngeal Squamous Cell Carcinoma: a Real-World Retrospective Study.

Wen-Jie Wu,Qian Liu,Pu-Gen An,Lin Wang,Jian-Yun Zhang,Yan Chen,Tong Zhang,Jie Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1346845

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1282629.].
Corrigendum: Case report: Long remission and survival following immunotherapy in a case of pulmonary pleomorphic carcinoma

Tongshan Wang,Muyang Chen,Anpeng Wang,Hao Zhang

DOI: https://doi.org/10.3389/fimmu.2024.1530843

IF: 7.3

2024-12-03

Frontiers in Immunology

Abstract:This article is a correction to: Case Report: Long Remission and Survival Following Immunotherapy in a Case of Pulmonary Pleomorphic Carcinoma

immunology
Corrigendum: Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy Can Benefit the Locally Advanced Rectal Cancer Patients with Clinically Positive Lateral Pelvic Lymph Node

Shuai Li,Yangzi Zhang,Yang Yu,Xianggao Zhu,Jianhao Geng,Huajing Teng,Zhilong Wang,Tingting Sun,Lin Wang,Hongzhi Wang,Yongheng Li,Aiwen Wu,Yong Cai,Weihu Wang

DOI: https://doi.org/10.3389/fonc.2021.790945

IF: 4.7

2021-12-14

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.627572.].

oncology
Correction to: Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβkinase activity and interrupting NF-κB/COX-2-mediated signaling cascades

Xun Wang,Zhenlong Yu,Chao Wang,Wei Cheng,Xiangge Tian,Xiaokui Huo,Yan Wang,Chengpeng Sun,Lei Feng,Jinshan Xing,Yulong Lan,Dongdong Sun,Qingjuan Hou,Baojing Zhang,Xiaochi Ma,Bo Zhang

DOI: https://doi.org/10.1186/s13046-020-01699-4

2020-09-23

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Corrigendum: Comparison of Clinical Outcomes Between Cone Beam CT-guided Thermal Ablation and Helical Tomotherapy in Pulmonary Metastases from Hepatocellular Carcinoma

Feihang Wang,Shisuo Fan,Qi Shi,Ding Zhao,Huaifeng Sun,Yav Sothea,Mengfei Wu,Huadan Song,Yi Chen,Jiemin Cheng,Zhao‐Chong Zeng,Yan Zhang,Jian He,Lingxiao Liu

DOI: https://doi.org/10.3389/fonc.2022.1038584

IF: 4.7

2022-01-01

Frontiers in Oncology

Abstract:In the published article, there was an error in affiliation of Zhaochong Zeng and Jian He. Instead of” Zhaochong Zeng2”and “Jian He2*”, the Shanghai Institute of Medical Imaging, Fudan University, Shanghai, China, it should be “Zhaochong Zeng4” and “Jian He4*”, the Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Correction: Radiopharmaceutical-activated silicon naphthalocyanine nanoparticles towards tumor photodynamic therapy

Tingting Wang,Jingchao Li,Xun Zhang,Chengao Li,Jiang Ming,Jian Li,Dongsheng Zhang,Jun Yang,Nian Liu,Xinhui Su

DOI: https://doi.org/10.1039/d4cc90284j

2024-08-29

Abstract:Correction for 'Radiopharmaceutical-activated silicon naphthalocyanine nanoparticles towards tumor photodynamic therapy' by Tingting Wang et al., Chem. Commun., 2024, https://doi.org/10.1039/d4cc03281k.
Correction: Allogeneic Hematopoietic Stem Cell Transplantation Should Be in Preference to Conventional Chemotherapy As Post-Remission Treatment for Adults with Lymphoblastic Lymphoma

Luxin Yang,Yamin Tan,Jimin Shi,Yanmin Zhao,Yuanyuan Zhu,Yongxian Hu,Wenjue Pan,Yishan Ye,Jingsong He,Weiyan Zheng,Jie Sun,Zhen Cai,He Huang,Yi Luo

DOI: https://doi.org/10.1038/s41409-020-0962-x

2020-01-01

Bone Marrow Transplantation

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Junfeng Zhang,Wei Xue,Kai Xu,Liang Yi,Yu Guo,Tian Xie,Haipeng Tong,Bo Zhou,Shunan Wang,Qing Li,Heng Liu,Xiao Chen,Jingqin Fang,Weiguo Zhang

DOI: https://doi.org/10.7150/thno.92042

IF: 11.6

2023-11-17

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.44427.].
Effect of neoadjuvant iodine-125 brachytherapy upon resection of glioma

Congxiao Wang,Chao Liu,Jun Chen,Han Jiang,Wei Zhang,Lili Yang,Xueda Li,Zixiang Li,Lijing Peng,Xiaokun Hu,Peng Sun

DOI: https://doi.org/10.1186/s12885-022-09504-5

IF: 4.638

2022-04-12

BMC Cancer

Abstract:Abstract Background A more extensive surgical resection of glioma contributes to improved overall survival (OS) and progression-free survival (PFS). However, some patients miss the chance of surgical resection when the tumor involves critical structures. Purpose The present study aimed to assess the feasibility of neoadjuvant 125 I brachytherapy followed by total gross resection for initially inoperable glioma. Methods Six patients diagnosed with inoperable glioma due to invasion of eloquent areas, bihemispheric diffusion, or large tumor volume received 125 I brachytherapy. Surgical resection was performed when the tumor shrank, allowing a safe resection, assessed by the neurosurgeons. Patients were followed up after surgery. Results Shrinkage of the tumor after adjuvant 125 I brachytherapy enabled a total gross resection of all six patients. Four patients were still alive at the last follow-up, with the longest survival time of more than 50 months, two of which returned to everyday life with a KPS of 100. Another two patients had neurological injuries with KPSs of 80 and 50, respectively. One patient with grade II glioma died 34 months, and another with grade IV glioma died 40 months after the combined therapy. Conclusions In the present study, the results demonstrated that 125 I brachytherapy enabled a complete resection of patients with initially unresectable gliomas. 125 I brachytherapy may offer a proper neoadjuvant therapy method for glioma.

oncology
Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer

Jihui Chen,Zhipeng Wang,Shouhong Gao,Kejin Wu,Fang Bai,Qiqiang Zhang,Hongyu Wang,Qin Ye,Fengjing Xu,Hong Sun,Yunshu Lu,Yan Liu

DOI: https://doi.org/10.1186/s12935-021-01876-1

IF: 6.429

2021-03-25

Cancer Cell International

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology

Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Correction to: Molecular landscape of IDH-mutant primary astrocytoma Grade IV/Glioblastomas

Correction to: GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma

Author Correction: Suppression of Glioblastoma by a Drug Cocktail Reprogramming Tumor Cells into Neuronal Like Cells

Correction to: LTBP1 plays a potential bridge between depressive disorder and glioblastoma

Correction: A highly X-ray sensitive iridium prodrug for visualized tumor radiochemotherapy

Corrigendum: Combined Scutellarin and C18H17NO6 Imperils the Survival of Glioma: Partly Associated With the Repression of PSEN1/PI3K-AKT Signaling Axis

Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M + diffuse midline gliomas

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Author Correction: Selective, high-contrast detection of syngeneic glioblastoma in vivo

Corrigendum: Neoadjuvant Tislelizumab Combined with Chemotherapy in Locally Advanced Oral or Oropharyngeal Squamous Cell Carcinoma: a Real-World Retrospective Study.

Corrigendum: Case report: Long remission and survival following immunotherapy in a case of pulmonary pleomorphic carcinoma

Corrigendum: Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy Can Benefit the Locally Advanced Rectal Cancer Patients with Clinically Positive Lateral Pelvic Lymph Node

Correction to: Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβkinase activity and interrupting NF-κB/COX-2-mediated signaling cascades

Corrigendum: Comparison of Clinical Outcomes Between Cone Beam CT-guided Thermal Ablation and Helical Tomotherapy in Pulmonary Metastases from Hepatocellular Carcinoma

Correction: Radiopharmaceutical-activated silicon naphthalocyanine nanoparticles towards tumor photodynamic therapy

Correction: Allogeneic Hematopoietic Stem Cell Transplantation Should Be in Preference to Conventional Chemotherapy As Post-Remission Treatment for Adults with Lymphoblastic Lymphoma

Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Effect of neoadjuvant iodine-125 brachytherapy upon resection of glioma

Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer